About Diagnosing Africa
.Diagnosing Africa is a concept development stage company whose primary focus is the development and manufacture of a multiplex rapid diagnostic test that would identify the cause of acute febrile illness.
Our larger mission is to increase access to diagnostics in lower-income and lower-middle-income countries through technology transfer and sustainable local production.
We are currently operating as a registered 501(c)3 corporation that is focused on research and product development of a lateral flow immunoassay for the diagnosis of acute febrile illness. Once assay and process development is complete we would commence the transfer of technology to a Limited Liability Company (LLC) that would be located in Ghana, West Africa.